venerdì, 27 novembre 2020
Medinews
3 Dicembre 2018

Human medicine European public assessment report (EPAR): Osimertinib (AstraZeneca)

November 30, 2018 – This Human medicine European public assessment report (EPAR) was updated.
Leggi tutto

TORNA INDIETRO